Table 1 Basal clinical characteristics
All (n = 21) | Women (n = 4) | Men (n = 17) | p | |
|---|---|---|---|---|
Age years old | 63 (12) | 66 (11) | 62 (12) | 0.596 |
Sex (Men) (%) | 17 (81) | |||
BMI (kg/m2) | 37.4 (6.4) | 37.4 (6.4) | 36.9 (4.7) | 0.855 |
Waist (cms) | 122 (13) | 117 (20) | 108 (17) | 0.349 |
Hip (cms) | 119 (15) | 125.9 (15) | 115 (16) | 0.293 |
Arm (cms) | 34.1 | 34.3 (6.3) | 33.8 (2.9) | 0.945 |
Smoker (%) | 11 (52) | 0 (0) | 10 (62.5) | 0.020 |
Alcohol (%) | 3 (14) | 1 (25) | 2 (12.5) | 0.496 |
HBP (%) | 16 (76) | 3 (75) | 12 (75) | 0.950 |
DM (%) | 20 (95) | 3 (75) | 16 (100) | 0.035 |
Dyslipaemia (%) | 16 (72) | 3 (75) | 13 (81) | 0.950 |
AF (%) | 5 (24) | 0 (0) | 5 (31.3) | 0.214 |
HF (%) | 4 (19) | 0 (0) | 4 (25) | 0.281 |
LVEF (%) | 53 (9.4) | 61 (0.9) | 52 (9.0) | 0.001 |
CAD (%) | 8 (38) | 0 (0) | 7 (43.8) | 0.081 |
CVA (%) | 1 (5) | 0 (0) | 1 (6.3) | 0.608 |
CKD (%) | 4 (19) | 0 (0) | 4 (25) | 0.281 |
OSA (%) | 5 (24) | 0 (0) | 4 (25) | 0.364 |
ACEi (%) | 5 (24) | 0 (0) | 4 (25) | 0.214 |
ARB (%) | 5 (24) | 1(25) | 4 [25] | 0.950 |
ARNI (%) | 3 (14) | 0 (0) | 3 (18.8) | 0.430 |
MRA (%) | 8 (38) | 0 (0) | 7 (43.8) | 0.081 |
B-B (%) | 11 (52) | 1 (75) | 9 (56.3) | 0.223 |
Antipl (%) | 9 (43) | 0 (0) | 8 (50) | 0.054 |
OAC (%) | 5 (24) | 0 (0) | 5 (31.3) | 0.241 |
Statins (%) | 19 (91) | 3 (75) | 15 (93.8) | 0.241 |
Ezetimibe (%) | 12 (57) | 0 (0) | 11 (68.8) | 0.010 |
Metformin (%) | 14 (67) | 2 (50) | 11 (68.8) | 0.432 |
SGLT2i (%) | 16 (76) | 3 (75) | 12 (75) | 0.950 |
Insulin (%) | 6 (29) | 1 (25) | 4 (25) | 0.867 |